Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Datadog, Inc. stock logo
DDOG
Datadog
$102.03
+0.1%
$132.57
$98.80
$170.08
$34.97B1.224.05 million shs6.87 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.73
-1.0%
$26.28
$24.48
$31.54
$145.79B0.6140.13 million shs37.26 million shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Datadog, Inc. stock logo
DDOG
Datadog
+0.07%-11.35%-30.64%-34.90%-17.04%
Pfizer Inc. stock logo
PFE
Pfizer
-1.05%-0.78%-0.54%+1.40%-8.16%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Datadog, Inc. stock logo
DDOG
Datadog
4.8367 of 5 stars
4.43.00.03.03.33.31.9
Pfizer Inc. stock logo
PFE
Pfizer
4.8876 of 5 stars
2.33.04.24.22.83.33.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Datadog, Inc. stock logo
DDOG
Datadog
2.77
Moderate Buy$158.7055.55% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.50
Moderate Buy$31.9224.09% Upside

Current Analyst Ratings Breakdown

Latest DDOG and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/4/2025
Datadog, Inc. stock logo
DDOG
Datadog
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$160.00 ➝ $160.00
2/18/2025
Datadog, Inc. stock logo
DDOG
Datadog
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
2/14/2025
Datadog, Inc. stock logo
DDOG
Datadog
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$170.00 ➝ $165.00
2/14/2025
Datadog, Inc. stock logo
DDOG
Datadog
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$150.00 ➝ $140.00
2/14/2025
Datadog, Inc. stock logo
DDOG
Datadog
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
2/14/2025
Datadog, Inc. stock logo
DDOG
Datadog
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$187.00 ➝ $180.00
2/14/2025
Datadog, Inc. stock logo
DDOG
Datadog
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$160.00 ➝ $160.00
2/13/2025
Datadog, Inc. stock logo
DDOG
Datadog
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$152.00 ➝ $140.00
2/12/2025
Datadog, Inc. stock logo
DDOG
Datadog
Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$148.00 ➝ $160.00
2/11/2025
Datadog, Inc. stock logo
DDOG
Datadog
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$200.00 ➝ $200.00
(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Datadog, Inc. stock logo
DDOG
Datadog
$2.68B13.03$0.32 per share323.21$6.12 per share16.67
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.29$4.03 per share6.38$15.81 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Datadog, Inc. stock logo
DDOG
Datadog
$183.75M$0.51200.06179.0044.036.85%8.28%4.55%5/6/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4118.248.490.6412.62%19.47%8.09%4/29/2025 (Estimated)

Latest DDOG and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/13/2025Q4 2024
Datadog, Inc. stock logo
DDOG
Datadog
$0.44$0.13-$0.31$0.13$713.85 millionN/A
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Datadog, Inc. stock logo
DDOG
Datadog
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.69%+2.50%121.99%16 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Datadog, Inc. stock logo
DDOG
Datadog
N/A
2.13
2.13
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73

Institutional Ownership

CompanyInstitutional Ownership
Datadog, Inc. stock logo
DDOG
Datadog
78.29%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Datadog, Inc. stock logo
DDOG
Datadog
11.78%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Datadog, Inc. stock logo
DDOG
Datadog
5,200342.76 million299.70 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable

Recent News About These Companies

Guggenheim Reaffirms Their Buy Rating on Pfizer (PFE)
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Shares Down 1.5% - Here's Why
Pfizer Inc. stock logo
Guggenheim Reiterates "Buy" Rating for Pfizer (NYSE:PFE)
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Sold by AGF Management Ltd.
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Trading Down 1.8% - What's Next?
Arvinas, Pfizer Report Positive Phase 3 VERITAC-2 Results
Pfizer: Undervalued Safe Haven In Risk-Off Market​
Pfizer: Undervalued Safe Haven In Risk-Off Market​

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Datadog stock logo

Datadog NASDAQ:DDOG

$102.03 +0.07 (+0.07%)
Closing price 03/12/2025 04:00 PM Eastern
Extended Trading
$102.52 +0.48 (+0.48%)
As of 03/12/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Datadog, Inc. operates an observability and security platform for cloud applications in North America and internationally. The company's products comprise infrastructure and application performance monitoring, log management, digital experience monitoring, continuous profiler, database monitoring, data streams and universal service monitoring, network monitoring, incident management, workflow automation, observability pipelines, cloud cost and cloud security management, application security management, cloud SIEM, sensitive data scanner, and CI visibility. Datadog, Inc. was incorporated in 2010 and is headquartered in New York, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$25.72 -0.27 (-1.02%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$25.76 +0.03 (+0.12%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.